Maryland Heights, MO, February 14, 2017 --(PR.com
)-- The global dermatology diagnostics and therapeutics market was valued at USD 19.3 Billion in 2015 and is estimated to reach USD 22.5 Billion by 2020, at a CAGR of 3.1% from 2016 to 2020, due to rising acute and chronic skin disorders worldwide.
Browse Dermatology Diagnostics and Therapeutics Market by Diagnostic Products (Dermatoscopes, Imaging, Microscopes, and Trichoscopes), Therapeutic Products (Antibacterial, Antifungal, Antiviral, Biological, Corticosteroids, Immunosuppressant, and Retinoids) and Product Pipeline (Clinical Phase 1, 2 and 3) 2016-2020 report at https://www.ihealthcareanalyst.com/report/dermatology-diagnostics-therapeutics-market/
Dermatology diagnostics and therapeutics mainly include chronic and acute skin diseases such as acne, rosacea, psoriasis, squamous cell carcinoma, eczema, dermatitis, and pruritus are major health concerns worldwide and account for a large portion of health care associated financial burden. Diagnosis and treatment of skin abnormalities and diseases covers both medical and surgical aspects dealing with the skin, nails, hair and its diseases along with various topical therapies for specific skin diseases such as dermatitis, warts, and tumors. The most common skin conditions are moles, chickenpox, acne, rashes, hives, eczema (atopic, allergic, or nummular dermatitis), skin cancer, rosacea, seborrheic dermatitis (causing cradle cap or dandruff), psoriasis, vitiligo, impetigo, and warts.
The global dermatology diagnostics and therapeutics market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on diagnostic products (dermatoscopes, imaging, microscopes, and trichoscopes), therapeutic products (antibacterial, antifungal, antiviral, biological, corticosteroids, immunosuppressant, and retinoids) and their product pipeline (clinical phase 1, 2 and 3) and forecasts growth trends (CAGR% - 2016 to 2020). The global dermatology diagnostics and therapeutics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global dermatology diagnostics and therapeutics market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global dermatology diagnostics and therapeutics market and included in this report are Agfa HealthCare NV, Astellas Pharma US, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech Inc., GlaxoSmithKline plc, LEO Pharma A/S, Michelson Diagnostics Limited, Novartis AG, Valeant Pharmaceuticals International, Inc.
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/dermatology-diagnostics-therapeutics-market/
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043